Stock Events

Stock Events

Direxion Daily S&P Biotech Bull 3X Shares

M$1,980

147

+M$55+2.86% Friday 19:50

Statistics

Day High

1,980

Day Low

1,900

52W High

3,000

52W Low

898.2

Volume

651

Avg. Volume

683

Mkt Cap

-

P/E Ratio

-

Dividend Yield

0.46%

Dividend

9.03

Upcoming

Dividends

0.46%Dividend Yield

10Y Growth

N/A

5Y Growth

23.69%

3Y Growth

N/A

1Y Growth

140.42%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LABU.MX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares, the inverse ETF of LABU, offering 3X leveraged exposure in the opposite direction.

ProShares Ultra Nasdaq Biotechnology 2X Shares

ProShares Ultra Nasdaq Biotechnology, a 2X leveraged ETF focusing on the biotech sector, similar to LABU but with less leverage.

ProShares UltraShort Nasdaq Biotechnology -2x Shares

ProShares UltraShort Nasdaq Biotechnology, offers 2X leveraged inverse exposure to the biotech sector, competing with LABU's bear counterpart.

SPDR S&P Biotech ETF, a non-leveraged ETF that tracks the biotech sector, competing for the same investor base as LABU.

iShares Biotechnology

iShares Nasdaq Biotechnology ETF, another major non-leveraged biotech ETF, competing in the biotech investment space with LABU.

VanEck Vectors Biotech ETF, offers exposure to the biotech industry, competing with LABU for biotech-focused investments.

First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund, a non-leveraged ETF competing in the biotech sector investment space.

ALPS Medical Breakthroughs

ALPS Medical Breakthroughs ETF, focuses on smaller companies in the biotech sector, offering a different approach but still competing for biotech investors.

ARK Genomic Revolution

ARK Genomic Revolution ETF, focuses on genomics and biotech, competing with LABU by targeting innovation in the biotech space.

Invesco Biotechnology & Genome

Invesco Dynamic Biotechnology & Genome ETF, offers exposure to the biotech and genomic sector, competing for similar investment interests.

About

The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

Show more...

CEO

Country

US

ISIN

US25460G1206

Listings